Data platform helping cell and gene therapy developers exploit their experimental data, a 'Google Maps for cells'.
| Date | Round | Amount |
|---|---|---|
| May 2026 | Pre Seed Tolemy Bio (UK) closed a 1.4M euro pre-seed led by Norrsken Evolve to help cell and gene therapy developers exploit their experimental data. | $1.6M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.